Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Radiotherapy Dosage"" wg kryterium: Temat


Tytuł :
In Regard to Shuryak et al.
Autorzy :
Welsh JS; Department of Radiation Oncology, Stritch School of Medicine, Loyola University, Chicago, Illinois; Department of Radiation Oncology, Edward Hines, Jr. VA Hospital, Hines, Illinois.
Bevelacqua J; Bevelacqua Resources, Richland, Washington.
Mortazavi SMJ; Medical Physics and Engineering Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Sacks B; FDA (retired medical officer), Gaithersburg, Maryland.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Oct 01; Vol. 111 (2), pp. 574-576.
Typ publikacji :
Letter; Comment
MeSH Terms :
Radiotherapy Dosage*
Humans
Opinia redakcyjna
Tytuł :
In Regard to Frankart et al.
Autorzy :
Laurent PA; Department of Radiation Oncology and INSERM U1030 Molecular Radiotherapy, Gustave Roussy Cancer Campus, Villejuif, France.
Ka K; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Gachot B; Department of Infectious Diseases, Gustave Roussy Cancer Campus, Villejuif, France.
de Kerangal Q; Department of Surgery, Division of Maxillofacial Surgery, Gustave Roussy Cancer Campus, Villejuif, France.
Descols P; Department of Surgery, Division of Dentistry, Gustave Roussy Cancer Campus, Villejuif, France.
Brau JJ; Department of Surgery, Division of Dentistry, Gustave Roussy Cancer Campus, Villejuif, France.
Blanchard P; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Benmoussa N; Department of Head and Neck Surgery, Gustave Roussy Cancer Campus, Villejuif, France.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Oct 01; Vol. 111 (2), pp. 582-584.
Typ publikacji :
Letter; Comment
MeSH Terms :
Radiotherapy Dosage*
Humans
Opinia redakcyjna
Tytuł :
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.
Autorzy :
Scott JG; Translational Hematology and Oncology Research, Radiation Oncology Department, Cleveland Clinic, Cleveland, OH, USA; Systems Biology and Bioinformatics, Case Western Reserve University, Cleveland, OH, USA.
Sedor G; School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Ellsworth P; School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Scarborough JA; Translational Hematology and Oncology Research, Radiation Oncology Department, Cleveland Clinic, Cleveland, OH, USA; Systems Biology and Bioinformatics, Case Western Reserve University, Cleveland, OH, USA.
Ahmed KA; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA.
Oliver DE; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA.
Eschrich SA; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA.
Kattan MW; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Torres-Roca JF; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2021 Sep; Vol. 22 (9), pp. 1221-1229. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji :
Journal Article
MeSH Terms :
Radiotherapy Dosage*
Neoplasms/*radiotherapy
Radiation Genomics/*methods
Databases, Factual ; Humans ; Neoplasms/genetics ; Neoplasms/mortality ; Precision Medicine ; Recurrence ; Survival Rate
Czasopismo naukowe
Tytuł :
In Regard to Deek et al.
Autorzy :
Onal C; Department of Radiation Oncology, Başkent University Faculty of Medicine, Adana Dr Turgut Noyan Research and Treatment Center, Adana, Turkey.
Guler OC; Department of Radiation Oncology, Başkent University Faculty of Medicine, Adana Dr Turgut Noyan Research and Treatment Center, Adana, Turkey.
Oymak E; Division of Radiation Oncology, Iskenderun Gelisim Hospital, Hatay, Turkey.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Aug 01; Vol. 110 (5), pp. 1546-1547.
Typ publikacji :
Letter; Comment
MeSH Terms :
Radiotherapy Dosage*
Humans
Opinia redakcyjna
Tytuł :
In Regard to Papachristofilou et al.
Autorzy :
Bevelacqua JJ; Bevelacqua Resources, Richland, Washington.
Welsh JS; Department of Radiation Oncology, Edward Hines Jr VA Hospital, Hines, Illinois; Department of Radiation Oncology, Stritch School of Medicine, Loyola University, Chicago, Illinois.
Mortazavi SMJ; Medical Physics and Engineering Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Aug 01; Vol. 110 (5), pp. 1550-1551. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji :
Letter; Comment
MeSH Terms :
Radiotherapy Dosage*
Humans
Opinia redakcyjna
Tytuł :
CBCT imaging: a simple approach for optimising and evaluating concomitant imaging doses, based on patient-specific attenuation, during radiotherapy pelvis treatment.
Autorzy :
Ordóñez-Sanz C; Radiotherapy Physics, St Bartholomew's Hospital, London, UK.
Cowen M; North West Anglia NHS Foundation Trust, England, UK.
Shiravand N; Radiotherapy Physics, St Bartholomew's Hospital, London, UK.
MacDougall ND; Radiotherapy Physics, St Bartholomew's Hospital, London, UK.; Barts Cancer Institute, Queen Mary University of London, London, UK.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2021 Aug 01; Vol. 94 (1124), pp. 20210068.
Typ publikacji :
Journal Article
MeSH Terms :
Cone-Beam Computed Tomography*
Radiotherapy Dosage*
Radiotherapy, Image-Guided*
Pelvic Neoplasms/*radiotherapy
Female ; Humans ; Male ; Phantoms, Imaging ; Pilot Projects ; Radiation Dosage ; Retrospective Studies
Czasopismo naukowe
Tytuł :
In Regard to Vasmel et al.
Autorzy :
Tsoutsou PG; Radiation Oncology Department, Geneva University Hospital, Geneva, Switzerland; University of Geneva, Faculty of Medicine, Geneva, Switzerland.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Jul 15; Vol. 110 (4), pp. 1250-1251.
Typ publikacji :
Letter; Comment
MeSH Terms :
Radiotherapy Dosage*
Humans
Opinia redakcyjna
Tytuł :
Dosimetry during adjuvant I therapy in patients with differentiated thyroid cancer-clinical implications.
Autorzy :
Szumowski P; Department of Nuclear Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland. .
Abdelrazek S; Department of Nuclear Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Iwanicka D; Department of Nuclear Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Mojsak M; Department of Nuclear Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Sykała M; Department of Nuclear Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Żukowski Ł; Department of Nuclear Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Siewko K; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Adamska A; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Maliszewska K; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Popławska-Kita A; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Szelachowska M; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Krętowski A; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Myśliwiec J; Department of Nuclear Medicine, Medical University of Bialystok, M. Skłodowskiej-Curie St. 24A, 15-276, Bialystok, Poland.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Jul 06; Vol. 11 (1), pp. 13930. Date of Electronic Publication: 2021 Jul 06.
Typ publikacji :
Journal Article
MeSH Terms :
Radiotherapy Dosage*
Iodine Radioisotopes/*therapeutic use
Thyroid Neoplasms/*radiotherapy
Absorption, Radiation ; Female ; Humans ; Male ; Middle Aged ; Neck/diagnostic imaging ; Thyroid Neoplasms/diagnostic imaging ; Tissue Distribution ; Tomography, Emission-Computed, Single-Photon ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis.
Autorzy :
Versluis JM; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
Hendriks AM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands.
Weppler AM; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
Brown LJ; Department of Medical Oncology, Westmead and Blacktown Hospitals, Cnr Hawkesbury Road and Darcy Road, Westmead, NSW 2145, Australia.
de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.
Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht Cancer Center, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.
Zimmer L; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147 Essen, Germany.
Kapiteijn EW; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 AZ, Leiden, the Netherlands.
Allayous C; AP-HP Dermatology Department, Saint-Louis Hospital, Université de Paris, 1 Avenue Claude Vellefaux, 75010 Paris, France.
Johnson DB; Department of Medical Oncology, Vanderbilt University Medical Center, 1211 Medical Center Dr, Nashville, TN 37232, United States.
Hepner A; Melanoma Institute Australia, 40 Rocklands Rds, Wollstonecraft, NSW 2065, Australia; Medical Oncology Service, Instituto Do Cancer Do Estado de Sao Paulo, Av Dr Amaldo, 251 Cerqueira César, Sao Paulo 01246-000, Brazil.
Mangana J; Department of Dermatology, University Hospital Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.
Bhave P; Department of Medical Oncology, Alfred Hospital, 55 Commercial Rd, Melbourne, VIC 3004, Australia.
Jansen YJL; Department of Surgical Oncology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Jette, Belgium.
Trojaniello C; Department of Medical Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Via Mariano Semmola, 80131 Napoli, NA, Italy.
Atkinson V; Department of Medical Oncology, Princess Alexandra Hospital, University of Queensland, 199 Ipswich Road, Woolloongabba, QLD 4102, Australia.
Storey L; University of Manchester and Christie NHS Foundation Trust, Wimslow Rd, Manchester M20 4BX, United Kingdom.
Lorigan P; University of Manchester and Christie NHS Foundation Trust, Wimslow Rd, Manchester M20 4BX, United Kingdom.
Ascierto PA; Department of Medical Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Via Mariano Semmola, 80131 Napoli, NA, Italy.
Neyns B; Department of Surgical Oncology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Jette, Belgium.
Haydon A; Department of Medical Oncology, Alfred Hospital, 55 Commercial Rd, Melbourne, VIC 3004, Australia.
Menzies AM; Melanoma Institute Australia, 40 Rocklands Rds, Wollstonecraft, NSW 2065, Australia; University of Sydney, Camperdown, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Reserve Rd, St Leonards, NSW 2065, Australia.
Long GV; Melanoma Institute Australia, 40 Rocklands Rds, Wollstonecraft, NSW 2065, Australia; University of Sydney, Camperdown, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Reserve Rd, St Leonards, NSW 2065, Australia.
Lebbe C; AP-HP Dermatology Department, Saint-Louis Hospital, Université de Paris, 1 Avenue Claude Vellefaux, 75010 Paris, France.
van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands; Department of Radiology & Nuclear Medicine Erasmus MC Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
Carlino MS; Department of Medical Oncology, Westmead and Blacktown Hospitals, Cnr Hawkesbury Road and Darcy Road, Westmead, NSW 2145, Australia; Melanoma Institute Australia, 40 Rocklands Rds, Wollstonecraft, NSW 2065, Australia; University of Sydney, Camperdown, NSW 2006, Australia.
Sandhu S; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
van Tinteren H; Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands.
Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Internal Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 AZ Leiden, the Netherlands.
Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jul; Vol. 151, pp. 72-83. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Metastasectomy*/adverse effects
Metastasectomy*/mortality
Radiotherapy Dosage*
Immune Checkpoint Inhibitors/*therapeutic use
Melanoma/*drug therapy
Skin Neoplasms/*drug therapy
Aged ; Australia ; Disease Progression ; Europe ; Female ; Humans ; Immune Checkpoint Inhibitors/adverse effects ; Male ; Melanoma/immunology ; Melanoma/mortality ; Melanoma/secondary ; Middle Aged ; Neoplasm Staging ; Progression-Free Survival ; Retrospective Studies ; Risk Factors ; Skin Neoplasms/immunology ; Skin Neoplasms/mortality ; Skin Neoplasms/pathology ; Time Factors ; United States
Czasopismo naukowe
Tytuł :
Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas.
Autorzy :
Cerrato M; Department of Oncology, University of Torino, Torino, Italy.
Orlandi E; Department of Oncology, University of Torino, Torino, Italy.
Vella A; Department of Oncology, University of Torino, Torino, Italy.
Bartoncini S; Department of Oncology, University of Torino, Torino, Italy.
Iorio GC; Department of Oncology, University of Torino, Torino, Italy.
Bongiovanni D; Department of Oncology, University of Torino, Torino, Italy.
Capriotti F; Department of Oncology, University of Torino, Torino, Italy.
Boccomini C; Hematology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Vassallo F; Hematology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Cavallin C; Department of Oncology, University of Torino, Torino, Italy.
De Luca V; Department of Oncology, University of Torino, Torino, Italy.
Giglioli FR; Medical Physics Unit, A.O.U. Città della Salute e della Scienza, Torino, Italy.
Ricardi U; Department of Oncology, University of Torino, Torino, Italy.
Levis M; Department of Oncology, University of Torino, Torino, Italy.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2021 Jul 01; Vol. 94 (1123), pp. 20210012. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article
MeSH Terms :
Radiotherapy Dosage*
Lymphoma, B-Cell, Marginal Zone/*radiotherapy
Adult ; Female ; Humans ; Lymphoma, B-Cell, Marginal Zone/mortality ; Lymphoma, B-Cell, Marginal Zone/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Palliative Care ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
NMR-Based Metabolomics in Investigation of the Radiation Induced Changes in Blood Serum of Head and Neck Cancer Patients and Its Correlation with the Tissue Volumes Exposed to the Particulate Doses.
Autorzy :
Boguszewicz Ł; Department of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Bieleń A; 1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Ciszek M; Department of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Wendykier J; Radiotherapy Planning Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Szczepanik K; Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Skorupa A; Department of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Mrochem-Kwarciak J; Analytics and Clinical Biochemistry Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Składowski K; 1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Sokół M; Department of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Jun 11; Vol. 22 (12). Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Spectroscopy*
Metabolomics*
Radiotherapy Dosage*
Head and Neck Neoplasms/*blood
Head and Neck Neoplasms/*radiotherapy
Adult ; Aged ; Discriminant Analysis ; Dose Fractionation, Radiation ; Dose-Response Relationship, Radiation ; Female ; Humans ; Least-Squares Analysis ; Male ; Middle Aged ; Statistics, Nonparametric
Czasopismo naukowe
Tytuł :
Effects of a Unique Combination of the Whole-Body Low Dose Radiotherapy with Inactivation of Two Immune Checkpoints and/or a Heat Shock Protein on the Transplantable Lung Cancer in Mice.
Autorzy :
Nowosielska EM; Department of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology, 4 Kozielska St., 01-163 Warsaw, Poland.
Cheda A; Department of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology, 4 Kozielska St., 01-163 Warsaw, Poland.
Pociegiel M; National Centre for Nuclear Research Radioisotope Centre POLATOM, 7A Soltana St., 05-400 Otwock, Poland.
Cheda L; Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, 101 Żwirki i Wigury St., 02-089 Warsaw, Poland.
Szymański P; Department of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology, 4 Kozielska St., 01-163 Warsaw, Poland.; Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy, Faculty of Pharmacy, Medical University of Lodz, 1 Muszyńskiego St., 90-151 Lodz, Poland.
Wiedlocha A; Department of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology, 4 Kozielska St., 01-163 Warsaw, Poland.; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway.; Centre for Cancer Reprograming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, 0379 Oslo, Norway.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Jun 11; Vol. 22 (12). Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Transplantation*
Radiotherapy Dosage*
Whole-Body Irradiation*
Heat-Shock Proteins/*metabolism
Immune Checkpoint Proteins/*metabolism
Lung Neoplasms/*metabolism
Lung Neoplasms/*radiotherapy
Animals ; Clone Cells ; Lung/pathology ; Lymphocyte Count ; Lymphocytes, Tumor-Infiltrating ; Macrophages/pathology ; Mice, Inbred C57BL ; Tumor Stem Cell Assay
Czasopismo naukowe
Tytuł :
Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.
Autorzy :
Otani Y; Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 (D10) Yamada-oka, Suita, Osaka 565-0871, Japan.; Department of Radiology, Kaizuka city hospital, 3-10-20 Hori, Kaizuka, Osaka, 597-0015, Japan.
Ohno T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
Ando K; Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.; Department of Radiation Oncology, Gunma Prefectural Cancer Center, 617-1 Takabayashinishi-machi, Ota, Gunma 373-8550, Japan.
Murata K; Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
Kato S; Department of Radiation Oncology, Saitama Medical Univercity International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1298, Japan.
Noda SE; Department of Radiation Oncology, Saitama Medical Univercity International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1298, Japan.
Murofushi K; Department of Radiation Oncology, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan.; Department of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Honkomagome 3-18-22 Bunkyo, Tokyo 113-8677, Japan.
Ushijima H; Department of Radiation Oncology, Saitama Cancer Center, 780 Komuro, Ina, Kita Adachi-gun, Saitama 362-0806, Japan.
Yoshida D; Department of Radiation Oncology, Saku Central Hospital Advanced Care Center, 3400-28 Nakagomi, Saku, Nagano 385-0051, Japan.; Department of Radiation Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515, Japan.
Okonogi N; QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Isohashi F; Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 (D10) Yamada-oka, Suita, Osaka 565-0871, Japan.
Wakatsuki M; QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Nakano T; Department of Molecular Imaging and Theranostics, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Pokaż więcej
Źródło :
Journal of radiation research [J Radiat Res] 2021 May 12; Vol. 62 (3), pp. 502-510.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Asian Continental Ancestry Group*
Brachytherapy*
Radiotherapy Dosage*
Radiotherapy, Image-Guided*
Tomography, X-Ray Computed*
Neoplasm Recurrence, Local/*pathology
Uterine Cervical Neoplasms/*radiotherapy
Adult ; Aged ; Feasibility Studies ; Female ; Humans ; Japan ; Middle Aged ; Organs at Risk
Czasopismo naukowe
Tytuł :
Three corrections for overshoot effect improved the dose for step-and-shoot intensity-modulated radiation therapy.
Autorzy :
Yu CY; Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan, Republic of China.; Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan, Republic of China.
Wan SW; Department of Health Physics Division, Institute of Nuclear Energy Research, Taichung, Taoyuan, Taiwan, Republic of China.
Weng YC; Department of Radiation Oncology,Nantou Hospital, Ministry of Health and Welfare, Nantou, Taiwan, Republic of China.
Hsu CH; Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan, Republic of China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Apr 23; Vol. 16 (4), pp. e0250243. Date of Electronic Publication: 2021 Apr 23 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Radiotherapy Dosage*
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*methods
Humans
Czasopismo naukowe
Tytuł :
Evaluation of a Monte Carlo-based algorithm for the influence of totally implantable venous access ports in external radiation therapy.
Autorzy :
Takeshita T; Department of Radiology, Teikyo University School of Medicine Mizonokuchi Hospital, 5-1-1 Futago Takatsu-ku, Kawasaki, Kanagawa, 213-8507, Japan.; Division of Medical Quantum Science, Department of Health Sciences, Kyushu University Graduate School of Medical Sciences School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Magome T; Department of Radiological Sciences, Komazawa University Faculty of Health Sciences Graduate School of Health Sciences, Tokyo, Japan.
Watanabe R; Department of Radiology, Teikyo University School of Medicine Mizonokuchi Hospital, 5-1-1 Futago Takatsu-ku, Kawasaki, Kanagawa, 213-8507, Japan.
Onozawa S; Department of Radiology, Teikyo University School of Medicine Mizonokuchi Hospital, 5-1-1 Futago Takatsu-ku, Kawasaki, Kanagawa, 213-8507, Japan.
Tsuchiya K; Tokyo Radiation Oncology Clinic, Tokyo, Japan.
Tago M; Department of Radiology, Teikyo University School of Medicine Mizonokuchi Hospital, 5-1-1 Futago Takatsu-ku, Kawasaki, Kanagawa, 213-8507, Japan.
Sasaki M; Division of Medical Quantum Science, Department of Health Sciences, Kyushu University Graduate School of Medical Sciences School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. .
Pokaż więcej
Źródło :
Japanese journal of radiology [Jpn J Radiol] 2021 Apr; Vol. 39 (4), pp. 387-394. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Algorithms*
Catheterization, Central Venous*
Monte Carlo Method*
Radiotherapy Dosage*
Radiotherapy Planning, Computer-Assisted/*methods
Humans ; Radiotherapy Planning, Computer-Assisted/instrumentation
Czasopismo naukowe
Tytuł :
The influence of beam delivery uncertainty on dose uniformity and penumbra for pencil beam scanning in carbon-ion radiotherapy.
Autorzy :
Li Y; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.; University of Chinese Academy of Sciences, Beijing, China.
Gao Y; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.; University of Chinese Academy of Sciences, Beijing, China.; Huizhou Research Center of Ion Science, Huizhou, China.
Liu X; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Shi J; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Xia J; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.; University of Chinese Academy of Sciences, Beijing, China.; Huizhou Research Center of Ion Science, Huizhou, China.
Yang J; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Mao L; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Apr 01; Vol. 16 (4), pp. e0249452. Date of Electronic Publication: 2021 Apr 01 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Radiotherapy Dosage*
Heavy Ion Radiotherapy/*methods
Heavy Ion Radiotherapy/instrumentation ; Humans ; Monte Carlo Method ; Neoplasms/radiotherapy ; Normal Distribution
Czasopismo naukowe
Tytuł :
TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells.
Autorzy :
Anbalagan S; The Institute of Cancer Research, London, UK.
Ström C; The Institute of Cancer Research, London, UK.
Downs JA; The Institute of Cancer Research, London, UK.
Jeggo PA; The Institute of Cancer Research, London, UK.; Genome Damage and Stability Centre, University of Sussex, Sussex, UK.
McBay D; The Institute of Cancer Research, London, UK.
Wilkins A; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.
Rothkamm K; University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Harrington KJ; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.
Yarnold JR; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.
Somaiah N; The Institute of Cancer Research, London, UK. .; The Royal Marsden NHS Foundation Trust, London, UK. .; The Royal Marsden, Downs Road, Sutton, SM2 5PT, UK. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Mar 29; Vol. 11 (1), pp. 7119. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Radiotherapy Dosage*
Tumor Suppressor Protein p53/*physiology
Cell Line, Tumor ; DNA/radiation effects ; DNA Breaks, Double-Stranded ; DNA End-Joining Repair ; Humans ; Radiation Tolerance
Czasopismo naukowe
Tytuł :
Dose-based optimisation for multi-leaf collimator tracking during radiation therapy.
Autorzy :
Mejnertsen L; ACRF Image X Institute, Faculty of Medicine and Health, University of Sydney, NSW, Australia.
Hewson E
Nguyen DT
Booth J
Keall P
Pokaż więcej
Źródło :
Physics in medicine and biology [Phys Med Biol] 2021 Mar 15; Vol. 66 (6), pp. 065027. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Radiotherapy Dosage*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*radiotherapy
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*methods
Algorithms ; Computer Simulation ; Humans ; Imaging, Three-Dimensional ; Male ; Motion ; Radiometry
Czasopismo naukowe
Tytuł :
Use of Receiver Operating Curve Analysis and Machine Learning With an Independent Dose Calculation System Reduces the Number of Physical Dose Measurements Required for Patient-Specific Quality Assurance.
Autorzy :
Hasse K; Department of Radiation Oncology, University of California, San Francisco, California. Electronic address: .
Scholey J; Department of Radiation Oncology, University of California, San Francisco, California.
Ziemer BP; Department of Radiation Oncology, University of California, San Francisco, California.
Natsuaki Y; Department of Radiation Oncology, University of California, San Francisco, California.
Morin O; Department of Radiation Oncology, University of California, San Francisco, California.
Solberg TD; FDA, Washington, District of Columbia.
Hirata E; Department of Radiation Oncology, University of California, San Francisco, California.
Valdes G; Department of Radiation Oncology, University of California, San Francisco, California.
Witztum A; Department of Radiation Oncology, University of California, San Francisco, California.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Mar 15; Vol. 109 (4), pp. 1086-1095. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article
MeSH Terms :
Machine Learning*
ROC Curve*
Radiotherapy Dosage*
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*methods
Humans ; Quality Assurance, Health Care
Czasopismo naukowe
Tytuł :
Dosimetric comparison between volumetric modulated arc therapy planning techniques for prostate cancer in the presence of intrafractional organ deformation.
Autorzy :
Varnava M; Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 (D10) Yamadaoka, Suita, Osaka, 565-0871, Japan.
Sumida I; Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 (D10) Yamadaoka, Suita, Osaka, 565-0871, Japan.
Oda M; Department of Medical Technology, Osaka University Hospital, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Kurosu K; Department of Medical Technology, Osaka University Hospital, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Isohashi F; Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 (D10) Yamadaoka, Suita, Osaka, 565-0871, Japan.
Seo Y; Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 (D10) Yamadaoka, Suita, Osaka, 565-0871, Japan.
Otani K; Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 (D10) Yamadaoka, Suita, Osaka, 565-0871, Japan.
Ogawa K; Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 (D10) Yamadaoka, Suita, Osaka, 565-0871, Japan.
Pokaż więcej
Źródło :
Journal of radiation research [J Radiat Res] 2021 Mar 10; Vol. 62 (2), pp. 309-318.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Radiotherapy Dosage*
Radiotherapy Planning, Computer-Assisted*
Radiotherapy, Intensity-Modulated*
Organs at Risk/*radiation effects
Prostatic Neoplasms/*radiotherapy
Humans ; Male ; Prostatic Neoplasms/diagnostic imaging
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies